Express News | Dongxing Healthcare: Net profit in 2023 will drop 5.15% year on year, and plans to pay 10 to 6 yuan

BreakingsApr 21 15:45

Dongxing Healthcare (301290.SZ) announced first-quarter results, net profit of 19.897 million yuan, an increase of 10.56%

Dongxing Medical (301290.SZ) released its report for the first quarter of 2024. The company's revenue was 91.814,700 yuan, an increase of 9.27% over the previous year. Net profit attributable to shareholders of listed companies was 19.897 million yuan, an increase of 10.56% over the previous year. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 12.313,900, a decrease of 5.20% over the previous year. Basic earnings per share were 0.2 yuan.

Zhitong FinanceApr 21 15:43

Dongxing Medical (301290.SZ): The product does not currently involve artificial intelligence technology

Gelonghui March 22丨An investor asked Dongxing Healthcare (301290.SZ) on the investor interactive platform, “Does the company's products use artificial intelligence technology?” The company replied that the company's products do not currently involve artificial intelligence technology.

Gelonghui FinanceMar 22 17:11

Dongxing Medical (301290.SZ): Product target overseas markets are mainly concentrated in the three major regions of South America, the Middle East and Europe

Gelonghui March 12 丨 Some investors asked Dongxing Healthcare (301290.SZ) on the investor interactive platform, “Does the company have related business in the US? Are there plans to launch and develop Ar-related products?” The company replied that many of the company's products have been certified by the US FDA, Brazil's ANVISA, and South Korea's KFDA according to the different medical device regulatory policies or practices of different overseas countries or regions. The company's target overseas markets are mainly concentrated in the three major regions of South America, the Middle East and Europe. The company will strive to expand overseas markets and increase its market share.

Gelonghui FinanceMar 12 16:21

Dongxing Healthcare (301290.SZ): As of March 8, 2024, the total number of shareholders of the company was 12,461

Gelonghui March 11 | Dongxing Medical (301290.SZ) said on the investor interactive platform that as of March 8, 2024, the total number of shareholders of the company was 12,461 (including credit accounts).

Gelonghui FinanceMar 11 15:09

Dongxing Medical (301290.SZ): At present, the company's endoscopic stapler has entered more than 300 domestic hospitals

Gelonghui March 8 | Dongxing Medical (301290.SZ) said on the investor interactive platform that at present, the company's endoscopic staplers have entered more than 300 domestic hospitals, mainly in the top three hospitals.

Gelonghui FinanceMar 8 15:10